Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jul-24 8:04 PM View:  | Healy James Director | Rapport Therapeutics, Inc. (RAPP) | 01-Jul-24 | Purchase | 44,032 | $24.52 | $1,079,580.00 | 2% 1.95M to 2.0M | |
| 10-Jun-24 7:38 PM View: | Healy James Director | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Conversion | 1,392,740 | -- | -- | 100% 0 to 1.39M | |
| 10-Jun-24 7:46 PM View: | Arch Venture Partners Xii, ... 10% Owner | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Conversion | 3,728,740 | -- | -- | 100% 0 to 3.73M | |
| 10-Jun-24 7:42 PM View: | Third Rock Ventures V, L.P. 10% Owner | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Conversion | 6,551,450 | -- | -- | 1122% 583.78K to 7.14M | |
| 10-Jun-24 7:38 PM View: | Healy James Director | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Purchase | 558,824 | $17.00 | $9,500,010.00 | 40% 1.39M to 1.95M | |
| 10-Jun-24 7:42 PM View: | Third Rock Ventures V, L.P. 10% Owner | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Conversion | 969,218 | -- | -- | 14% 7.14M to 8.1M |
